Old Web
English
Sign In
Acemap
>
Paper
>
P16.05 Real World Data of First-Line Treatment With Pembrolizumab for Highly PD-L1-Expressing NSCLC
P16.05 Real World Data of First-Line Treatment With Pembrolizumab for Highly PD-L1-Expressing NSCLC
2021
M. Kobayashi
H. Mizugaki
Y. Ikezawa
R. Morita
Kazunari Tateishi
K. Yokoo
T. Sumi
Hajime Kikuchi
Y. Nagano
Atsushi Nakamura
M. Aso
N. Kimura
F Yoshiike
Megumi Furuta
Hiroshi Tanaka
M. Sekikawa
Tsutomu Hachiya
Yuka Fujita
Satoshi Oizumi
Keywords:
Oncology
real world data
PD-L1
Medicine
Pembrolizumab
Internal medicine
first line treatment
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]